v3.25.2
Cover
Jun. 17, 2025
Entity Addresses [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 17, 2025
Entity File Number 001-41293
Entity Registrant Name Aspire Biopharma Holdings, Inc.
Entity Central Index Key 0001847345
Entity Tax Identification Number 33-3467744
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 23150 Fashion Drive
Entity Address, Address Line Two Suite 232
Entity Address, City or Town Estero
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33928
City Area Code (415)
Local Phone Number 592-7399
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common stock, par value $0.0001 per share  
Entity Addresses [Line Items]  
Title of 12(b) Security Common stock, par value $0.0001 per share
Trading Symbol ASBP
Security Exchange Name NASDAQ
Warrants, each exercisable for one share of common stock  
Entity Addresses [Line Items]  
Title of 12(b) Security Warrants, each exercisable for one share of common stock
Trading Symbol ASBPW
Security Exchange Name NASDAQ
Former Address [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One 194 Candelaro Drive
Entity Address, Address Line Two #233
Entity Address, City or Town Humacao
Entity Address, Country PR
Entity Address, Postal Zip Code 00791